On the eve of the 1920s, digital transformation of research and health processes entered a phase of rapid evolution. The biotechnological drug inserts itself in a heterogeneous therapeutic ecosystem, in which it coexists with traditional drugs, digital therapy and digital solutions to support patients.

The meeting involves patients, health professionals, pharmacologists, experts in therapy and digital solutions to take stock of the progress made along this path and to provide guidance and recommendations for the next steps.

Venue: tbd (Pavia o Milano)

Focus: Red Biotech

Type: Meeting/Debate

More info: massimo.vergnano@argonnetwork.com

Organiser: MavericksConsulting e Fondazione Smith Kline